Active, Not Recruiting
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
NCT03161353
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Institute Jules Bordet Brussels, Belgium
- CLCC d'Auvergne. Centre Jean Perrin. Clermont-Ferrand, France
- Institute de Cancerologie de Laurraine Nancy, France
- Groupe Hospitalier Diaconesses Paris, France